News
Result of Special Meeting & Director Shareholdings
16 November 2015
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM JAPAN, CANADA OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.
Further to the announcement dated 4 November 2015, TyraTech, Inc. (AIM:TYR and TYRU), a life sciences company focusing on nature-derived insect and parasite control products, is pleased to announce that at the Special Meeting held earlier today, each of the resolutions as set out in the notice of Special Meeting was duly passed. Accordingly, the Fundraise (as defined in the circular dated 4 November 2015) is now unconditional save for Admission.
Accordingly, the Company has approved, subject only to Admission, the issue of 105,333,333 new common shares in the capital of the Company of $0.001 each (the "New Common Shares") at 3 pence per share to the investors participating in the Fundraise.
Application has been made to the London Stock Exchange for the New Common Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission and the commencement of dealings will take place at 8 a.m. on 18 November 2015.
Following Admission, the Company will have 367,666,444 common shares of $0.001 each ("Common Shares") in issue, of which 1,084,413 will continue to be held in Treasury. Therefore, the total number of voting rights in the Company will be 366,582,031 ("Total Voting Rights"). The number of restricted Common Shares trading under TIDM 'TYR' following Admission will be 219,677,899 and the number of unrestricted Common Shares trading under TIDM 'TYRU' following Admission will be 147,988,545.
Furthermore, following Admission, there are changes to the following directors' holdings of Common Shares:
Alan Reade, who subscribed for 1,050,004 New Common Shares pursuant to the Subscription, is now interested in 13,783,620 Common Shares in the Company; representing an interest of 3.76% of the total voting rights of the Company.
Bruno Jactel, who subscribed for 435,733 New Common Shares pursuant to the Subscription, is now interested in 2,438,157 Common Shares in the Company; representing an interest of 0.67% of the total voting rights of the Company.
Barry Riley, who subscribed for 525,000 New Common Shares pursuant to the Subscription, is now interested in 3,723,413 Common Shares in the Company; representing an interest of 1.02% of the total voting rights of the Company.
James Hills, who subscribed for 539,200 New Common Shares pursuant to the Subscription, is now interested in 1,779,957 Common Shares in the Company representing an interest of 0.49% of the total voting rights of the Company.
| TyraTech Inc. Alan Reade, Non-Executive Chairman Bruno Jactel, Chief Executive Officer |
Tel: +44 7841978709 Tel: +1 919 415 4340 |
| SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44203 368 3551 |
| Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: +44 20 3328 5656 |
| Whitman Howard Limited, Joint Broker Ranald McGregor-Smith/ Niall Devins |
Tel: +44 20 7087 4555 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.